LATEST ARTICLES

October 31, 2014: Cancer Leaders Call for Congress to Act Quickly in 2015 to Reinvigorate Cancer Innovation in the U.S.

Created on: Friday, October 31, 2014

Even before the next Congress is formally elected, a national group of healthcare stakeholders called the Cancer Innovation Coalition (CIC) took the unusual step of going to Capitol Hill to call for early legislative and regulatory action in 2015 that will reinvigorate cancer innovation in the U.S.

(Read More)

October 31, 2014: Employment, Mergers and Joint Ventures: More Radiology Groups Exploring New Ways to Work With Hospitals

Created on: Friday, October 31, 2014

From 2010 to 2013, the ACR Commission on Human Resources’ annual workforce survey reports a 10% drop in radiology groups—from approximately 2,100 to some 1,900. Edward Bluth, MD, the radiology department chairman emeritus at the New Orleans-based Ochsner Clinic Foundation, serves as the commission chairman.

(Read More)

October 31, 2014: Cigna Says Sales Will Double As Fee-For-Service Medicine Goes Away

Created on: Friday, October 31, 2014

Health insurance giant Cigna CI +2.07% (CI), beating profit forecasts for the third quarter, raised its earnings forecast for the rest of the year and said it will double revenues in the next seven to eight years on growth driven in part by the shift away from fee-for-service medicine to “value-based” care.

(Read More)

October 31, 2014: PhRMA Reports Show Promise, Challenges of Oncology Therapies (with Chart: Cancer Medicines in Development by Disease and Phase)

Created on: Friday, October 31, 2014

Pharmaceutical manufacturers are maintaining their research-and-development focus on oncology, with 771 therapies, including vaccines, in the pipeline, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA), released Oct. 7.

(Read More)

October 31, 2014: Clinical Trial Participation Low in Lung, Colorectal Cancers

Created on: Friday, October 31, 2014

Despite the importance of clinical trials for driving medical discovery and innovations, only 14% of patients with newly diagnosed lung or colorectal cancer surveyed in a recent trial reported having discussed participation in clinical trials with their physician, and even fewer went on to participate.

(Read More)

October 31, 2014: Dangerous Drug Shortages

Created on: Friday, October 31, 2014

Dozens of essential medications are in critically short supply. Here's what you need to know

(Read More)

October 31, 2014: Prostate Cancer Medications Linked with Increased Risk of Heart-Related Deaths in Men with Cardiovascular Problems

Created on: Friday, October 31, 2014

A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks.

(Read More)

October 30, 2014: Google Developing a Pill That Would Detect Cancer and Other Diseases

Created on: Thursday, October 30, 2014

Google is attempting to develop a pill that would send microscopic particles into the bloodstream in an effort to identify cancers, imminent heart attacks, and other diseases.

(Read More)

October 30, 2014: New Melanoma Drug Shows Benefits In Trial, With Limitations

Created on: Thursday, October 30, 2014

A new cancer drug benefited 51% of stage III and IV melanoma patients during a phase II trial, achieving complete response (total cancer disappearance) in 26% during the treatment period.

(Read More)

October 30, 2014: Therapy treats lung cancer based on patients’ genetic markers

Created on: Thursday, October 30, 2014

A new type of clinical trial for lung cancer patients getting under way at hospitals in the Bay Area and around the country may change the way drugs are tested in the future.

(Read More)

|1| 2 | Next >>

Blog Home

TedOkonCOA TWITTER

Community Oncology Alliance
1101 Pennsylvania Avenue, N.W.
Suite 700
Washington, DC 20004
(202) 756-2258